Regeneron Earnings Move Forecast
Reuters reported on 23‑Oct‑2026 that Bloomberg‑compiled options data suggests Regeneron Pharmaceuticals Inc. (REGN) shares could move 4.4% when the company releases its earnings report on 30 October before the market opens. The forecast is based on the implied volatility derived from options pricing.
The article highlights that in four of the last eight earnings announcements, the stock’s actual price change exceeded the options‑implied move. Specific historical comparisons are provided:
- On 30 July, options implied a 6.3% move, but the stock rose 13.4%.
- On 29 April, an implied 5.6% move preceded an actual 8.2% decline.
- On 30 January, the implied move was 5.2%, while the stock changed 1.9%.
- On 28 October 2025, options indicated a 5.7% move and the stock surged 13.5%.
- On 1 August 2025, a 6.6% implied move resulted in a 1.0% decline.
- On 29 April 2025, the implied move was 6.3%, with an actual change of 1.3%.
- On 4 February 2025, options suggested a 5.5% move, and the stock changed 1.8%.
- On 31 October 2024, a 3.6% implied move preceded an 11.0% decline.
The piece notes that the stock has moved more than the options‑implied amount in half of the recent earnings cycles, indicating a tendency for larger-than‑expected price swings.
The article was generated with AI assistance and subsequently reviewed by an editor, as indicated by the disclaimer. No comments were posted by readers at the time of publication.
---